When contemplating return of soreness or withdrawal on account of adverse activities as lack of response (LTR), procedure with LYRICA resulted in a longer time to loss of therapeutic response than treatment with placebo. Fifty-3 percent on the pregabalin-treated subjects as compared to 33% of placebo sufferers remained on examine drug and taken car